A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT04985136 · TERMINATED
Trial details
- NCT number
- NCT04985136
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-26
- Primary completion
- 2021-12-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.